Metrics as of 10/13/2026, 06:39 PM (Berlin time), refresh in progress.
MDxHealth Stock
MDxHealth S.A.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- Belgium
- CEO
- Michael K. McGarrity
- Employees
- 364
- Market cap
- $33 M
- IPO
- 04/11/2021
MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European nations such as the Netherlands, Belgium, Spain, Poland, Italy, and the wider European Union. The company's innovative…
MDxHealth stock: price history
1D
+4.3%
1W
+5.0%
1M
-10.6%
6M
-72.2%
YTD
-82.4%
1Y
-85.0%
2Y
-68.5%
5Y
–
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~40% weaker price swings than usual
Ask the agents about MDxHealth
Analyst assessment of MDxHealth
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.50
MEDIAN
US$2.50
PRICE TARGET HIGH
US$3.00
0
STRONG BUY
6
BUY
0
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 21/08/2026
MDxHealth stock metrics
P/E
-1.08
P/B
-1.1
EV/EBITDA
-15.41
RETURN ON EQUITY
37.9%
NET MARGIN
-42.4%
DEBT/EQUITY
-3.48
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
80.9%
FLOAT SHARES
41,567,452
AVG. DAILY VOLUME (30D)
211,150
Insider transactions (SEC)
MVM Partners, LLC
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about MDxHealth stock
What does MDxHealth do?
MDxHealth S.A. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in Belgium.
The CEO is Michael K. McGarrity, the company employs around 364 people.
The IPO was on 04/11/2021; the stock trades on NASDAQ under the ticker MDXH.
What do analysts say about MDxHealth stock?
6 analysts rate the stock, the consensus is Buy (as of 21/08/2026).
The average price target is US$2.50, ranging from US$2.00 to US$3.00, with a median of US$2.50.
This is an external assessment, not a statement by Market Jury.
When does MDxHealth report next?
Around past earnings, price swings were roughly -40% stronger than usual.
Does MDxHealth pay a dividend?
No, MDxHealth currently does not pay a dividend.
Which stocks are comparable to MDxHealth?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get MDxHealth stock analyzed?
Clicking "Analyze stock" lets five strategies assess MDxHealth against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.